XRF ScientificASX:XRF -1.69%98 5-Year Yield-on-Cost % is 10.34 as of Jul. 08, 2026, which is 28% above its 10-year median of 8.09. GuruFocus rates ASX:XRF with a GF Score™ of 98/100 and a GF Value™ of A$1.65 (Fairly Valued). The stock has 1 warning sign investors should review. Among 368 Conglomerates companies, XRF Scientific ranks better than 86.14% on this metric.
XRF Scientific's yield on cost for the quarter that ended in Dec. 2025 was 10.34.
The historical rank and industry rank for XRF Scientific's 5-Year Yield-on-Cost % or its related term are showing as below:
ASX:XRF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 4.07 Med: 8.09 Max: 22.22
Current: 10.34
During the past 13 years, XRF Scientific's highest Yield on Cost was 22.22. The lowest was 4.07. And the median was 8.09.
ASX:XRF's 5-Year Yield-on-Cost % is ranked better than 86.14% of 368
companies
in the Conglomerates industry
Industry Median: 3.62
vs ASX:XRF: 10.34
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
XRF Scientific 5-Year Yield-on-Cost % Related Terms
ASX:XRF vs HON, MMM: 5-Year Yield-on-Cost % Comparison
For the Conglomerates subindustry, XRF Scientific's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific 5-Year Yield-on-Cost % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where XRF Scientific's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of XRF Scientific is calculated as
XRF Scientific (ASX:XRF) has a 5-Year Yield-on-Cost % of 10.34 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on XRF Scientific and its competitors. This is 28% above median its historical median of 8.09. Over the past decade, XRF Scientific's 5-Year Yield-on-Cost % has ranged from 4.07 to 22.22. According to the industry distribution chart, XRF Scientific ranks #51 out of 368 companies in the Conglomerates industry, placing it in the top 13.9%.
Is XRF Scientific's 5-Year Yield-on-Cost % too high?
XRF Scientific's current 5-Year Yield-on-Cost % of 10.34 is 28% above median its 10-year median of 8.09. Over the past 10 years, this metric has ranged from a low of 4.07 to a high of 22.22. The Conglomerates industry median 5-Year Yield-on-Cost % is 3.62. XRF Scientific's value of 10.34 is 185.6% above this industry median. Based on the distribution chart, XRF Scientific ranks #51 out of 368 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, XRF Scientific has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's 5-Year Yield-on-Cost % compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #51 out of 368 companies for 5-Year Yield-on-Cost %. This places XRF Scientific in the top 14% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.62. XRF Scientific's value of 10.34 is 185.6% above this benchmark. Historically, XRF Scientific's own 5-Year Yield-on-Cost % has ranged from 4.07 to 22.22 over the past decade. While the company's 10-year median is 8.09 vs. the industry median of 3.62, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Conglomerates company?
The median 5-Year Yield-on-Cost % among Conglomerates companies is 3.62, based on 368 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current 5-Year Yield-on-Cost % of 10.34 is 185.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median 5-Year Yield-on-Cost % is 3.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current 5-Year Yield-on-Cost % is 10.34, which is 28% above median its own 10-year median of 8.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.74 — trading 5.5% above its estimated fair value. The current 5-Year Yield-on-Cost % is 10.34, which is 28% above median its 10-year median of 8.09 and 185.6% above the Conglomerates industry median of 3.62. XRF Scientific's overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current 5-Year Yield-on-Cost % is 10.34 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.74 is trading 5.5% above its estimated GF Value™ of A$1.65.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
5-Year Yield-on-Cost %: 10.34 (28% above median its 10-year median of 8.09)
GF Value™: A$1.65 vs. price of A$1.74 (5.5% above fair value)
Industry Position: 185.6% above the Conglomerates median (#51 of 368)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
98GF Score
Get the complete analysis for ASX:XRF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 